Informatica from Salesforce has announced a comprehensive series of strategic partnership expansions designed to empower enterprises to build, deploy, and scale trusted agentic AI workflows across ...
In its first major announcement since being acquired by Salesforce Inc., data management vendor Informatica today unveiled a “headless” version of its flagship Intelligent Data Management Cloud, ...
Going back to grad school has long been the Plan B of young professionals who aspire to climb higher in their careers or struggle to get promoted in a tough job market. New data show that getting a ...
ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min After the original project was ...
Salesforce Inc. today released details about its thinking in acquiring Informatica Inc. despite that company’s apparent overlap with Salesforce’s MuleSoft integration subsidiary. Executives said the ...
Ai agentic models might be incredibly intelligent, but they're corporately stupid. The $8 billion solution to all this is the coming together of Salesforce and Informatica, say execs from each firm.
Learn how to master the backflip quickly and safely with this easy step-by-step tutorial. Perfect for beginners and .anyone looking to improve their gymnastics skills! #BackflipTutorial ...
Informatica, a leader in enterprise AI-powered cloud data management, is offering its Fall 2025 release, introducing new innovations that connect enterprise data to the next generation of AI agents.
An increased number of requests for digitalization and data across the firm’s business processes has led to paint manufacturer Jotun giving its data management platform a makeover. Jotun, which ...
Patients with previously untreated, locally advanced, unresectable or metastatic triple-negative breast cancer who are not candidates for inhibitors of programmed cell death protein 1 (PD-1) or ...